Thymosin beta-4 monograph

Thymosin beta-4

Overview

TB-500 is the bodybuilding/gym name commonly used for a thymosin beta-4-derived peptide. Thymosin beta-4 is an endogenous 43-amino-acid peptide implicated in tissue repair, inflammation modulation, and angiogenesis in preclinical literature, but TB-500 itself is not an FDA-approved drug and human evidence for performance or injury healing is very limited. Because the marketed product name is often used loosely, dosing claims online are mostly anecdotal and should not be treated as established medical guidance.

Pharmacokinetics & Mechanism

• Class: Endogenous actin-binding peptide; investigational regenerative peptide / research chemical
• Mechanism of action: Best-supported mechanisms are preclinical: binding/sequestering G-actin, modulating cell migration, inflammation, angiogenesis, and wound repair signaling. The fragment sold as TB-500 is generally discussed as a thymosin beta-4-related peptide, but exact clinical pharmacology of the bodybuilding product is not well established in humans.
• Target(s): Actin cytoskeleton dynamics (G-actin sequestration); downstream pathways associated with cell migration, wound repair, angiogenesis, and inflammation. Human receptor-level targets are not well established; much of the biology is inferred from thymosin beta-4 preclinical work rather than TB-500 clinical studies.
• Route(s) of administration: Primarily subcutaneous injection in community use; intramuscular and intravenous use are discussed anecdotally. No approved labeled route exists for TB-500.
• Onset: Not well established in humans. Community users often describe perceived effects over days to weeks rather than immediately.
• Half-life: Not well established for TB-500 in humans. Thymosin beta-4 itself is a small peptide with rapid proteolytic degradation expected; no reliable human half-life standard for the bodybuilding product was found. Extended-duration claims for 'TB-500' are not well established and should not be assumed to mean a true long half-life.
• Metabolism / clearance: Likely rapid peptide/proteolytic degradation with amino-acid recycling and general peptide clearance pathways. Human metabolism and clearance data for TB-500 are not well established; there is no authoritative human PK package for the bodybuilding product.